Arlington Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Arlington Partners's MRK Position: Q1 2024 in Review
Arlington Partners sold out of Merck (MRK) in Q1 2024, closing a stake of 1,046 shares — an estimated $114K sold.
Arlington Partners first reported a position in MRK in Q1 2018 and held it in 24 quarters. The position peaked at $662K in Q2 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Arlington Partners reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
- Arlington Partners sold 1,046 Merck shares in Q1 2024, an estimated $114K.
- Arlington Partners first reported a position in Merck in Q1 2018 and held it in 24 quarters.
- Arlington Partners's Merck position peaked at $662K in Q2 2023.
- 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.